Yahoo Web Search

  1. Ads
    related to Leukemia
  1. Agios' Tibsovo Meets Endpoint in Cholangiocarcinoma Study

    Zacks via Yahoo FinanceMay 16 14:49 PM

    AGIO announced that its leukemia drug Tibsovo (ivosidenib) met the primary endpoint in a late-stage study, which evaluated it for the previously treated IDH1 mutant cholangiocarcinoma ...

  2. The meeting will be held in conjunction with a program that involves multiple oncology stakeholders in the creation of a model disaster response program for cancer patients. The goal is to have ...

  3. Jazz Pharma (JAZZ) Q1 Earnings and Sales Beat Estimates

    Zacks via Yahoo FinanceMay 08 12:01 PM

    Jazz Pharmaceuticals plc JAZZ delivered adjusted earnings of $3.67 per share for the first quarter of 2019, which surpassed the Zacks Consensus Estimate of $3.16. Total revenues in the reported ...

  4. Stemline Therapeutics Inc (NASDAQ: STML) reported a wider first-quarter net loss per share Friday, dragged by higher R&D expenses, which nearly tripled from a year ago. Wedbush analyst David ...

  5. ImmunoGen (IMGN) Misses on Earnings & Revenues in Q1

    Zacks via Yahoo FinanceMay 06 13:44 PM

    ImmunoGen, Inc. IMGN reported adjusted loss of 30 cents per share for the first quarter of 2019, wider than the Zacks Consensus Estimate of a loss of 28 cents. ImmunoGen’s shares have significantly ...

  6. NASDAQ: ARNA) Avedro Inc (NASDAQ: AVDR) Axsome Therapeutics Inc (NASDAQ: AXSM) MeiraGTx Holdings PLC (NASDAQ: MGTX) Shockwave Medical Inc (NASDAQ: SWAV) Silk Road Medical Inc (NASDAQ: SILK) ...

  7. Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL

    Zacks via Yahoo FinanceMay 17 21:19 PM

    The company is a seeking label expansion of the drug for the first-line treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The nod was based on data ...

  8. Bank of America Merrill Lynch 2019 Healthcare Conference – May 13-15, in Las Vegas Oppenheimer 4th Annual Emerging Growth Conference – May 14, in New York Oppenheimer Oncology Insight Summit ...

  9. Kura Oncology, Inc. (KURA) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceMay 08 0:49 AM

    I would now like to introduce your host for today's conference, Mr. Pete De Spain, Kura's vice president of investor relations. Joining me on the call from Kura are Dr. Troy Wilson, our president ...

  10. Xencor Inc (XNCR) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceMay 10 13:23 PM

    I would now like to introduce your host for today's conference, Charles Liles, Associate Director and Head of Corporate Communications and Investor Relations. Good afternoon.This is Charles Liles of Xencor.

  1. Ads
    related to Leukemia